These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 9439694)

  • 1. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
    Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9439694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
    Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.
    Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
    J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. II. Structure elucidation of pyripyropenes A, B, C and D.
    Kim YK; Tomoda H; Nishida H; Sunazuka T; Obata R; Omura S
    J Antibiot (Tokyo); 1994 Feb; 47(2):154-62. PubMed ID: 8150710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs.
    Obata R; Sunazuka T; Kato Y; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1996 Nov; 49(11):1149-56. PubMed ID: 8982344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient total synthesis of novel bioactive microbial metabolites.
    Sunazuka T; Hirose T; Omura S
    Acc Chem Res; 2008 Feb; 41(2):302-14. PubMed ID: 18217720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic conversion of ACAT inhibitor to acetylcholinesterase inhibitor.
    Obata R; Sunazuka T; Otoguro K; Tomoda H; Harigaya Y; Omura S
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1315-6. PubMed ID: 10890154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. IV. Structure elucidation of pyripyropenes M to R.
    Tomoda H; Tabata N; Yang DJ; Namatame I; Tanaka H; Omura S; Kaneko T
    J Antibiot (Tokyo); 1996 Mar; 49(3):292-8. PubMed ID: 8626247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyripyropenes, Novel ACAT inhibitors produced by Aspergillus fumigatus. III. Structure elucidation of pyripyropenes E to L.
    Tomoda H; Tabata N; Yang DJ; Takayanagi H; Nishida H; Omura S; Kaneko T
    J Antibiot (Tokyo); 1995 Jun; 48(6):495-503. PubMed ID: 7622436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Astles PC; Ashton MJ; Bridge AW; Harris NV; Hart TW; Parrott DP; Porter B; Riddell D; Smith C; Williams RJ
    J Med Chem; 1996 Mar; 39(7):1423-32. PubMed ID: 8691472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
    Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
    Ohshiro T; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
    Ohnuma S; Muraoka M; Ioriya K; Ohashi N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2.
    Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK
    J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a new chemical lead for a matrix metalloproteinase inhibitor.
    Ikura M; Nakatani S; Yamamoto S; Habashita H; Sugiura T; Takahashi K; Ogawa K; Ohno H; Nakai H; Toda M
    Bioorg Med Chem; 2006 Jun; 14(12):4241-52. PubMed ID: 16481176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of acyl CoA:cholesterol acyltransferase.
    Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
    J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Hu H; Liao H; Zhang J; Wu W; Yan J; Yan Y; Zhao Q; Zou Y; Chai X; Yu S; Wu Q
    Bioorg Med Chem Lett; 2010 May; 20(10):3094-7. PubMed ID: 20403694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
    Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
    Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms.
    Tomoda H; Omura S
    Pharmacol Ther; 2007 Sep; 115(3):375-89. PubMed ID: 17614133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.